Role of transcatheter arterial embolization for massive bleeding from gastroduodenal ulcers

Table 1 Synopsis of the studies under review

Ref., yr	Patients (n)	Mean age (yr)	Previous endoscopy (%)	Active extravasation (%)	Technical success (%)
Lang et al[23], 1992	57	52	NA	100	91
Toyoda et al[33], 1995	11	65	100	54	100
Toyoda et al[37], 1996	30	62	100	NA	100
Walsh et al[43], 1999	50	64	100	50	92
De Wispelaere et al[40], 2002	28	69	100	39	89
Ljungdahl et al[19], 2002	18	78	72	50	72
Ripoll et al[24], 2004	31	75	100	NA	100
Holme et al[25], 2006	40	70	100	30	100
Eriksson et al[20], 2006	10	75	100	10	100
Loffroy et al[13], 2008	35	71	100	66	94
Larssen et al[15], 2008	36	80	100	42	92
van Vugt et al[35], 2009	16	71	100	75	88
Loffroy et al[26], 2009	60	69	100	63	95
All studies	422	69	98	53	93

NA: Not available.

Table 2 Outcomes in case-series that included more than 10 patients treated with endovascular embolization for peptic ulcer bleeding over a 17-year period

Ref., yr	Clinical success (%)	Re-bleeding rate (%)	Need for surgery (%)	Complication rate (%)	30-d mortality (%)
Lang et al[23], 1992	86	56	2	16	4
Toyoda et al[33], 1995	91	18	18	0	27
Toyoda et al[37], 1996	80	23	13	NA	23
Walsh et al[43], 1999	52	52	37	4	40
De Wispelaere et al[40], 2002	64	36	21	0	46
Ljungdahl et al[19], 2002	67	8	8	0	6
Ripoll et al[24], 2004	71	29	16	0	26
Holme et al[25], 2006	65	28	35	0	25
Eriksson et al[20], 2006	80	0	20	NA	NA
Loffroy et al[13], 2008	94	17	14	6	21
Larssen et al[15], 2008	72	9	30	8	17
van Vugt et al[35], 2009	81	19	12	NA	38
Loffroy et al[26], 2009	72	28	12	10	27
All studies	75	25	18	4	25

The table shows the rates of clinical success, recurrent bleeding after technically successful embolization, need for surgery to control the bleeding, complications, and peri-procedural mortality.